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Summary For the past 20 years thickness of the primary tumour has been accepted as the most important
guide to prognosis for patients with primary cutaneous malignant melanoma. The changing epidemiology of
melanoma with an increasing number of patients with thin tumours has necessitated a reappraisal of this, with
particular reference to interactions among tumour thickness, the patients' sex and the presence or absence of
ulceration ofthe primary tumour. All primary cutaneous malignant melanomas diagnosed in Scotland between
1979 and 1986 were used as the test group (1978 patients). The proportional hazards model was used on all
potential risk factors in the database and their two-way interactions, and the resulting models based on
stepwise procedures were subsequently validated on 289 melanoma patients first diagnosed in 1987 in the same
geographic area. Four distinct subgroups of males and females with ulcerated or non-ulcerated lesions were
identified. For females with ulcerated lesions, tumour thickness, mitotic count and anatomical site of primary
all gave valuable prognostic information, whereas for females with non-ulcerated lesions only tumour
thickness was of prognostic value. For males with ulcerated lesions, level of invasion was the only prognostic
guide, while for males with non-ulcerated lesions both tumour thickness and level of invasion contributed
significantly to prediction of prognosis. Prognosis is markedly different across subgroups of the melanoma
population, even to the extent that essential prognostic factors are not the same in the distinct subgroups.
Verification of these prognostic guides derived from 1979-86 patients has been achieved for all patients
diagnosed with melanoma in 1987 from the same geographic area. These data will therefore be useful aids for
clinicians managing patients.
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Over the past decade malignant melanoma of the skin has
attracted attention because of its rapidly rising incidence
(Maclennan et al., 1992). Melanoma-related mortality is also
rising, but at a slower rate. Overall, quoted 5 year survival
for large series is around 70%, but there are striking
differences within population subsets. Since the seminal
papers of the late Alexander Breslow, which established that
patient survival correlated well with thickness of the primary
tumour (Breslow, 1970, 1975), tumour thickness has been
used in all parts of the world as the main prognostic guide,
and in general this is justified. For example, in Scotland
overall 5 year disease-free survival for 1661 patients first
diagnosed as having primary melanoma between 1979 and
1984 was 72%, but when divided into three primary tumour
thickness categories - under 1.5 mm, 1.5-3.49 mm and
3.5 mm and over - the 5 year figures are 93%, 73% and 48%
respectively (MacKie et al., 1992). This, however, illustrates
the point that 7% of patients with thin tumours have died of
melanoma, while 52% of those with thick tumours are alive
and apparently tumour free at 5 years. It therefore appears
that other factors, possibly interacting with tumour thickness,
are also involved in the tumour-host relationship. Know-
ledge of these interrelationships is of increasing importance
as patients become more aware of the significance of their
diagnosis and require information on prognosis to enable
them to make realistic changes in their lifestyle. This is of
particular importance in patients with melanoma, a large
proportion of whom are relatively young and may have to
make important decisions about occupational changes or
care of children.
While the identification of such additional prognostic fac-
tors has been attempted for some time, there is still no clear
agreement on their relative significance. Balch et al. (1992)
have reported that, in their series, ulceration, even if only
visible microscopically, is the next most powerful predictor of
prognosis after thickness, but other groups have suggested
that mitotic rate, age, sex and anatomical site of the primary
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tumour are of greater prognostic significance (Vollmer, 1989).
Two recent publications have used data sets to develop com-
plex models aimed at more accurately predicting survival in
subsets of patients. Clark et al. (1989) have reported that for
patients with vertical growth phase melanoma there is an
important breakpoint with regard to survival for melanomas
at a thickness of 1.69 mm. Other independently significant
prognostic variables in the Clark model are anatomical site
of primary tumour (axial vs extremities), sex, mitotic count,
regression and a lymphocytic infiltrate within, not just
beneath, the tumour. There are two problems with the
general applicability of this model. The first is the relatively
small size of the data set and the second is the fact that the
terms radial and vertical growth phases are not well defined
or understood by general pathologists and are not used
routinely in pathology reports. Soong et al. (1992) using
combined data from Alabama and Sydney have shown that,
after controlling for tumour thickness, ulceration, level of
invasion, anatomical site of primary lesion and sex all have
an impact on survival. However, this group has not taken
their studies further in terms of offering a useful prognostic
model to colleagues, nor have they tested its applicability in
other geographic areas.
This type of information is clearly of value to the clinician
in identifying those patients at greatest nrsk of disease recur-
rence. This will have importance in counselling patients and
their relatives as well as suggesting appropriate intervals
between follow-up visits.
This present study has been carried out using the large
population of patients in the Scottish Melanoma Group
database, all drawn from the same geographic area, firstly to
better predict the prognosis of patients in this area and
thereafter to validate the model and use it as an aid to
counselling individual patients concerning prognosis.
Patients and methods
Patients
The study population on which these models were based are
the patients registered with the Scottish Melanoma GroupPi in mul_
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between 1979 and 1986. This group comprises all patients in
Scotland in whom the pathological diagnosis of invasive
cutaneous malignant melanoma was first made during these
years. The mean follow-up time is 5.2 years, the mean time
to death in non-survivors 3.0 years and the average follow-up
of survivors is 6.4 years.
At the time of registration, details of clinical, pathological
and treatment variables are entered. These include sex and
age of the patient, anatomical site of the tumour, tumour
thickness, level of invasion, histogenetic type, mitotic count,
presence of ulceration, regression or pre-existing naevus and
excision marins. Follow-up information is obtained
thereafter at regular intervals.
Statistical analysis
The full analysis on all available data pertaining to death due
to melanoma was carried out using the product-limit method
of survivor function estimation, Cox's proportional hazards
regression model and log-rank tests as appropriate (Everitt,
1989). The set of all potential prognostic factors such as
tumour thickness, age, sex, level ofinvasion, was analysed by
forward and backward stepwise variable selection techniques
to identify the important and solely essential prognostic fac-
tors. Two-way interactions of pairs of important prognostic
factors were also investigated for their effect on survival, and
used subsequently to derive subgroups ofpatients with differ-
ing important prognostic factors and hence different survival
prospects.
The appropriateness ofincluding any such factors (or their
intractions) in the proportional hazards (PH) model was
investigated by log-log survivor function plots for cate-
gorical factors and by the use of a non-parametric technique
for continuous factors which drops the assumption of
inearity of risk factors explicit in the exponential part of the
PH model. This non-parametric procedure was also used to
produce the illustrations of estimated survivor functions used
in this paper.
Redls
A total of 1978 patients were identified who were first diag-
nosed with primary cutaneous malignant melanoma between
1979 and 1986.
Table I shows the factors thought to influence prognosis
which have been studied. In our melanoma population, all
are significant prognostic variables when considered singly
for melanoma patients with stage I disease with the excep-
tion ofregression (whether seen in association with the verti-
cal or horizontal growth phases). In this analysis, tumour
thickness and age are treated as continuous variables, as we
have previously shown that in this population there are no
significant breakpoints in the population in either of these
variables. It is also worth noting that, in the individual
analysis of anatomical site, a significant difference was found
in prognoss for head and neck melanomas by comparison
with melanomas on the trunk and upper and lower limbs.
The collective importance of all these potential risk factors
was then investigated by stepwise procedures in which
significat risk factors are enterd in the model one at a time,
having corrected for the nsk factors already included in the
model by that step. This ensures that the final model, dis-
played in the right-hand column of Table I, contains only
prognostic factors whose contribution to prognosis is in addi-
tion to all other prognostic factors in the final model.
It will be seen that the two most powerful prognostic
variables (after suitable correction for each other) are ulcera-
tion and tumour thickness, with the sex of the patient as the
third most important variable. It is also clear that the order
ofimportance of these prognostic factors is quite different in
the output from the stepwise procedure by comparison with
that generated by the study of individual factors. As an
example, the mitotic count is in isolation the third most
important factor, but once corrected for ulceration, etc., falls
to seventh place. It is of practical value to note that all the
factors contributing prognostic information in our model are
easily available from clnical data or the routine pathological
report, and thus can be easily obtaied in a routine setting
outwith a specialist melanoma centre.
Two of the three collectively most important prognostic
factors (i.e. uklration and sex) take only two possible values.
In addition, uklcrated lesions tend to be associated with
thicker tumours, while non-ulcerated lesions are in general
thinner. Mainly for these reasons, but with the additional
evidence that a sex-uklcration interation with respect to
prognosis existed (P<0.0001), it was important to consider
the four distin subgroups of sex and ulcemation status -
males and females with uklrated or non-ulcerated lesions.
Stepwise proportional hazards models were then fitted to
the data from each of these four subgroups (Table H). It will
be seen that within these four subgroups the choice and
effects ofthe remaining signnt prognostic factors are very
different. This is particularly apparent for tumour thickness.
Table I Si of potential prognostic factors
Factor
Ulceration (present/absent)
Tumour thkness
Mitosis (low/medium/highf
Levl of invasion (Clark levl 2,
3, 4, 5)
Histgenetic typed
Age
Sex (male/female)
Anatomical site
(head and neck, trunk, upper
limbs and lower limbs)
Pre-exisig naevus (no/yes)
Re son associated with
vertical growth phase (no/yes)
Regression associated with
horizontal growth phase
(no/yes)
In&i6l sencm
on fuld survival da
i (df)' PJ
188 (1)
136 (1)
100 (2)
98 (3)
93 (4)
45 (1)
33 (1)
24 (3)
4 (1)
2 (1)
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.05
0.15
0.5 (1) 0.50
Order of inchtsio
in stepwie PH' model
Order X2 (df.)b P
1 188 (1) <0.01
2 52 (1) <0.01
7 8 (2) 0.02
6 15 (3) <0.01
8
4
3
5
4 (1)
13 (1)
22 (1)
15 (3)
0.05
<0.01
<0.01
<0.01
Not inchided
Not incuded
Not incuded
'Chi-squared vahls, degres offreedom and P-vahles for tests ofsign of bu /idual
factor. bAS above but for the iuchakm step of the factor in a forward stepwise proportional
hazards (PH) model. cv&ls of mitosis are: low = <1 per lOhp.f, medium = 1-5 per
10h.p.f, high = >5 per 10h.pf. 'Histogntic types are: lentigo maligna, supefical
spreadins, nodular, acal and otes In the stepwise aproach only the acral group showed a
significant differc among the types.
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Tabte n Significance of prognostic factors for sex/ulceration subgroups
No. of Per cent Signlicant risk factors for
complete alive after stepwise proportional hazards model
Subgroup cases 5 years Risk factors X2 (d.f)a
Females with 269 53% Tumour thickness 13 (1) <0.01
ulceration Mitosisb 10 (1) <0.01
Anatomical siteb 10 (1) <0.01
Females without 714 90% Tumour thickness 53 (1) <0.01
ulceration No other factors included
Males with 137 35% Level of invasionc 5 (1) 0.03
ulceration No other factors included
Males without 280 78% Tumour thickness 33 (1) <0.01
ulceration Level of invasiond 8 (1) <0.01
'Chi-square values, degrees of freedom and P-values for test of significance of the prognostic
risk factor when entered into the proportional hazards model. The factors are given in order of
entry to the model. bHere, after appropriate tests, mitosis was coded as low vs medium/high
while anatomical site was coded as axial vs extremity. cHere, after appropriate tests, level of
invasion was coded as levels 3 and 4 vs 5. dHere, after appropriate tests, levels of invasion was
coded as levels 4 and 5 vs the other levels.
Table m Summary of the performance of the survival analysis prognostic procedure on the SMG
1987 data
Nwnber of years after diagnosis
1987 Patient subgroup 1 2 3 4
Females with
ulcerated lesions
No. of patients at risk 46 44 44 33
Observed/predicted ratio' 42:42.4 36:33.9 33:30.3 21:19.8
Females with
non-ulcerated lesions
No. of patients at risk 151 149 143 132
Observed/predicted ratio' 150:149.9 148:146.5 141:139.5 129:126.8
Males with
ulcerated lesions
No. of patients at risk 32 30 30 28
Observed/predicted ratioa 28:29.1 20:22.1 18:18.5 15:13.7
Males with
non-ulcerated lesions
No. of patients at risk 71 68 66 61
Observed/predicted ratio' 71:69.2 65:63.3 61:59.8 54:51.8
'Ratio of observed patients to those predicted to survive beyond this time. Observed numbers are
those whose actual status (i.e. dead due to melanoma or not) was certain the appropriate number of
years after prognosis.
Table IV Predicted prognosis for groups of patients
model
classfied according to proportional hazards
Five year survival at three tumour
Patient subgroup thicknesses
Sex Ulceration Other factors n I mm 3mm 5mm
Female Without - 855 95% 90% 82%
(93, 96) (88,93) (77, 87)
Male Without Level of invasion 2 or 3 187 93% NA NA
(90,98)
Male Without Level of invasion 4 or 5 157 81% 72% 59%
(75, 89) (64, 80) (50,70)
Female With Extremity site 83 81% 80% 79%
few mitoses (70, 94) (72, 90) (69, 91)
Female With Axial site 43 75% 67% 56%
few mitoses (60, 94) (51, 87) (39, 79)
Female With Extremity site 143 62% 59% 57%
many mitoses (53, 72) (51, 69) (49, 66)
Female With Axial site 60 NA 62% 53%
many mitoses (48, 81) (40, 72)
Male With Level of invasion 3 or 4 154 53% 49% 45%
(43, 66) (41, 59) (37, 54)
Male With Level of invasion 5 32 NA NA 37%
(20, 69)
NA, not enough data to produce reasonabe prediction. Numbers in brackets are approximate 95%
confidence intervals.RM MaKi eti
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Females with ulcerate lesions have three furher features of
prognostic signi : tumour thickness, mitotic count in
tumour cells and anatomical site of primary tumour. If the
pnimary tumour is not ulcerated, tumour thickness is a very
important prognostic variable in both sexes, but its vale is
greatly diluted in the presence of ulcration, particularly for
males. For example males with ulcerated primary tumours
have a less than 50% chance of surviving 5 years irrespective
of level of invasion, but for other subgroups survival pro-
spects beyond 5 years are better.
The proportional hazards model based on these subgroups
and derived from patients diagnosed between 1979 and 1986
inclusive was then applied to patients first diagnosed in Scot-
land in 1987. For each patient in this validation sample, a
prediction ofsurvival status was estimated on the basis ofthe
1979-86 derived model and compared with actual status at
1, 2, 3 and 4 years' follow-up. The results are summarised in
Table Ill, from which it will be seen that there is exceilent
agreement between predited and actual total numbers of
survivors at the corresponding timeponts.
Based on the PH models for each distinct subgroup (Tabk
II), 5 year survival probabilities were calated to illustrate
prognosis for patients with melanomas 1 mm, 3 mm and
5 mm thick. This is shown in Table IV, from which it will be
seen that survival prospects vary greatly depending on the
sex of the patient and whether or not the lesion is ulcrated.
For example, melanomas of 1 mm are generally considered to
have a good prognosis, and this is true for non-ulerated
melanomas in women with 94% 5 year disease-free survival;
however, for a male with 1 mm lesion which is uklrated and
has invaded to Clark level 3 or 4, 5 year survival prospects
are only 51%. Conversely, a primary melanoma 5 mm thick
is considered as a poor prognosis lesion but, ifoccurring in a
female and non-ulcerated, 5 year disease-free survival pro-
spects are 82% for a tumour of the same thickness. These
figures make the point that for adequate counseling of
patients and their families, more information than just
tumour thickns must be considered. Table IV also makes
the point that risk of recurr is far higher in ulcerated
lesions, particularly in males, and that it might therefore be
prudent to follow up males at 3 monthly intervals for the
first 5 years after surgery, in the hope of detecting recur-
rences at a very early stage when further surgical intervention
is more likely to prolong survival.
The aim of this study has been to use sophiscated statistical
techniques on a large geographically based database to
obtain prognostic information relevant to that population,
and to identify subsets of patients with markedly different
survival prospects. All such models require validation, and
ours has been valdated within the same geographic area with
an independent patient population not used for the orginal
derivation of the model. Validation using a melanoma
patient group drawn from a different geographic area is now
required to test the geographic uniersality of the model.
This is important, as in our experience the models derived by
Clark et al. (1989) and by Soong et al. (1992) do not
accurately reflect the situation in Scotland. Not only do the
estimated survival prospects differ markedly in many of the
subgroups considered in these models, but the choice of
important prognostic features is substantially different. For
example, for tumours 0.76-1.49 mm thick the Soong model
incorporates anatomial site, uklration and level of invasion
as the important and essential prognostic features, whereas
exactly the same analysis on that subgroup for the Scottish
Melanoma Group database throws up a completely different
set of essential features, i.e. sex, age and regression in the
horzontal growth phase. However, even if the Soong et al.
model is appled, differences of up to 30% in 5 year survival
prospects were discovered between the Sydney/Alabama and
Scottish databases in other subgroups defined by the Soong
et al. choice of prognostic features.
Further experience empha the fact that carrying out
logistic regression to a fixed time point such as 8 years as in
the Clark model can seriously bias results if a larg number
ofcases are lost over time to folow-up. Omitting these cases
could underestimate survival prospects by as much as
10%.
Tlhis study emphasise the importance of approprate
statistical analyses to study the interaction between factors of
susected prognosic signiicance. The differng results in the
literature may well be due at least in part to a failure to
study these interactions fully, by only considering features of
putative prognostic signi in isolation. However, there
may also be geographic variation in prognostic factors, based
for example on subtle effects on the immune systm caused
by intense UV exposure in high melanoma incidence count-
ries such as Ausralia. It is hikely that in different parts ofthe
world where median tumour thicknesses differ, and the
incidence of melanoma is signiiantly different, these prog-
nostic models may be less relevant. Accordingly, each large
centre may need to derive its own model, i.e. set of rekvant
prognostic features and their interactions, from retrspective
data on which 5 year follow up at minimum is available, and
then validate it on a second data set from that area. We
would, however, anticipate that the model presented here will
be relevant at last to a northern European settng.
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